Analysis of the Major RNA Adduct Derived from Aminophenylnorharman, a Novel Endogenous Mutagen and Carcinogen

Genes and Environment

Volumn 29, Issue 2, 2007, Pages 54-62

  Totsuka, Yukari ^a   Nishigaki, Rena ^a   Takamura Enya, Takeji ^b   Kawahara, Nobuo ^c   Sugimura, Takashi ^a   Wakabayashi, Keiji ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b KANAGAWA INSTITUTE OF TECHNOLOGY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902836978     PISSN: 18807046     EISSN: 18807062     Source Type: Journal    
DOI: 10.3123/jemsge.29.54     Document Type: Article

References (27)

1. Totsuka Y, Hada N, Matsumoto K, Kawahara N, Murakami Y, Yokoyama Y, Sugimura T, Wakabayashi K. Structural determination of a mutagenic aminophenyl-norharman produced by the co-mutagen norharman with aniline. Carcinogenesis. 1998; 19: 1995-2000.
2. Sugimura T. A new concept of co-mutagenicity from a phenomenon forgotten for the past two decades: Is it more important than previously expected? Environ Health Perspect. 1998; 106: A522-23.
3. Kawamori T, Totsuka Y, Uchiya N, Kitamura T, Shibata H, Sugimura T, Wakabayashi K. Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats. Carcinogenesis. 2004; 25: 1967-72.
4. Totsuka Y, Takamura-Enya T, Nishigaki R, Sugimura T, Wakabayashi K. Mutagens formed from beta-carbolines with aromatic amines. J Chromatogr B. 2004; 802: 135-41.
5. Oda Y, Totsuka Y, Wakabayashi K, Guengerich FP, Shimada T. Activation of aminophenylnorharman, aminomethylphenylnorharman and aminophenylharman to genotoxic metabolites by human N-acetyltransferases and cytochrome P450 enzymes expressed in Salmonella typhimurium umu tester strains. Mutagenesis. 2006; 21: 411-16.
6. Totsuka Y, Takamura-Enya T, Kawahara, N, Sugimura T, Wakabayashi K. The structure of DNA adduct formed with aminophenylnorharman, being responsible for the co-mutagenic action of norharman with aniline. Chem Res Toxicol. 2002; 15: 1288-94.
7. Totsuka Y, Ushiyama H, Ishihara J, Sinha R, Goto S, Sugimura T, Wakabayashi K. Quantification of the co-mutagenic beta-carbolines, norharman and harman, in cigarette smoke condensates and cooked foods. Cancer Lett. 1999; 143: 139-43.
8. lARC. Aniline and Aniline Hydrochloride. lARC Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Humans. pp. 39-61, Lyon: France; 1982.
9. Luceri F, Pieraccini G, Moneti G, Dolara P. Primary aromatic amines from side-stream cigarette smoke are common contaminants of indoor air. Toxicol Ind Health. 1993; 9: 405-13.
10. Nishigaki R, Totsuka Y, Kataoka H, Ushiyama H, Goto S, Akasu T, Watanabe T, Sugimura T, Wakabayashi K. Detection of aminophenylnorharman, a possible endogenous mutagenic and carcinogenic compound, in human urine samples. Cancer Epidemiol Biomarkers Prevent. 2007; 16: 151-6.
11. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004; 339: 1-9.
12. Sharma RA, Farmer PB. Biological relevance of adduct detection to the chemoprevention of cancer. Clin Cancer Res. 2004; 10: 4901-12.
13. Kawanishi S, Hiraku Y, Pinlaor S, Ma N. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem. 2006; 387: 365-72.
14. Totsuka Y, Nishigaki R, Sugimura T, Wakabayashi, K. Mutagenic and carcinogenic heterocyclic amines-their possible involvement in human cancer. In: Skog K and Alexander J, editors. Acrylamide and Other Health Hazardous Compounds in Heat-treated Foods. pp. 296-327, Cambridge: England; 2006.
15. Sotomayor RE, Washington M, Nguyen L, Nyanganyi R, Hinton DM, Chou M. Effects of intermittent exposure to aflatoxin B1 on DNA and RNA adduct formation in rat liver: dose-response and temporal patterns. Toxicol Sci. 2003; 73: 329-38.
16. Surh YJ, Lai CC, Miller JA, Miller EC. Hepatic DNA and RNA adduct formation from the carcinogen 7-hydroxymethyl-12-methylbenz[a]anthracene and its electrophilic sulfuric acid ester metabolite in preweanling rats and mice. Biochem Biophys Res Commun. 1987; 144: 576-82.
17. Zhu P, Lee SH, Wehrli S, Blair lA. Characterization of a lipid hydroperoxide-derived RNA adduct in rat intestinal epithelial cells. Chem Res Toxicol. 2006; 19: 809-17.
18. Ohnishi S, Murata M, Oikawa S, Totsuka Y, Takamura T, Wakabayashi K, Kawanishi S. Oxidative DNA damage by an N-hydroxy metabolite of the mutagenic compound formed from norharman and aniline. Mutat Res. 2001; 494: 63-72.
19. Lobo AM, Marques MM, Prabhakar S, Rzepa HS. Tetrahedral intermediates formed by nitrogen and oxygen attack of aromatic hydroxylamines on acetyl cyanide. J Org Chem. 1987; 52: 2925-7.
20. Lobo AM, Marques MM, Prabhakar S, Rzepa HS. Tetrahedral intermediates formed during acyl transfer. Reactions of acetyl cyanide. J Chem Soc Chem Commun. 1985; 16: 1113-5.
21. Famulok M, Boche G. Formation of N-(deoxyguanosin-8-yl)aniline in the in vitro reaction of N-acetoxyaniline with deoxyguanosine and DNA. Angew Chem Int Ed Engl. 1989; 28: 468-9.
22. Gupta RC, Reddy MV, Randerath K. 32P-postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis. 1982; 3: 1081-92.
23. Randerath E, Agrawal HP, Weaver JA, Bordelon CB, Randerath K. 32P-postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin, epidermis and dermis of mice treated topically with 7,12-dimethyl-benz[a]anthracene. Carcinogenesis. 1985; 6: 1117-26.
24. Mori M, Totsuka Y, Fukutome K, Yoshida T, Sugimura T, Wakabayashi K. Formation of DNA adducts by the co-mutagen norharman with aromatic amines. Carcino-genesis. 1996; 17: 1499-503.
25. Fukutome K, Ochiai M, Wakabayashi K, Watanabe S, Sugimura T, Nagao M. Detection of guanine-C8-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine adduct as a single spot on thin-layer chromatography by modification of the 32P-postlabeling method. Jpn J Cancer Res. 1994; 85: 113-7.
26. Totsuka Y, Fukutome K, Takahashi M, Takahashi S, Tada A, Sugimura T, Wakabayashi K. Presence of N2-(deoxyguanisin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f ]quinoxaline (dG-C8-MeIQx) in human tissues. Carcinogenesis. 1996; 17: 1029-34.
27. Clawson GA, Smuckler EA. Increased amounts of double-stranded RNA in the cytoplasm of rat liver following treatment with carcinogens. Cancer Res. 1982; 42: 3228-31.